Aurora Cannabis Inc. has announced a strategic supply agreement with SNDL Inc. 

Under the agreement, SNDL is expected to supply Aurora with cannabis flower grown at SNDL’s indoor facility in Atholville, New Brunswick, where SNDL handles all of its cultivation. They acquired the facility from Zenabis in 2022. 

The term of the agreement between SNDL and Aurora is three years, with an option to extend and an estimated value of $27 million. 

“Following our strong, third quarter performance driven by record setting growth in our international medical cannabis segment, Aurora remains focused on a balanced approach to operating a hybrid manufacturing network of in-house and third-party cultivation. We value our relationship with SNDL and their shared commitment to cultivation excellence,” said Miguel Martin, Executive Chairman and Chief Executive Officer of Aurora Cannabis.

“As Canada’s leading integrated cannabis company, SNDL is well positioned as a supplier of quality cannabis products to commercial partners like Aurora. We have a shared approach to quality and cultivation excellence and look forward to expanding this relationship further,” said Zach George, Chief Executive Officer of SNDL. 

SNDL posted $236.9 million in revenue in the third quarter of 2024, with an $18.5 million loss in its most recent quarterly report last November. 

On February 5, 2025, Aurora Cannabis reported nearly $100 million in revenue for the three months ended December 31, 2024 (Q3 2025), $88.2 million in net revenue, and $31.3 million in net income, a new high for the company. 

Featured image of SNDL’s Atholvill facility via Google Maps

Related Articles

SNDL posts $3.8 million in adjusted operating income from its cannabis businesses in Q3 2024

November 5, 2024

SNDL announces successful bid to purchase Indiva 

August 29, 2024

Aurora Cannabis reports record-breaking quarter, continued increases in international market

February 5, 2025